Microdosing GLP-1 takes a different, more nuanced strategy that involves the clinician and patient working together to find the lowest effective dose to support personal goals such as improved mental clarity and energy, reduced inflammation, improved cardiometabolic health, moderate weight loss, or disease prevention and longevity
However, more evidence is needed to support this specific relationship along with further studies directed towards the effects of modulating levels of GSH on immune cell activity and programming in the CNS
The neurological effects can worsen, potentially leading to permanent cognitive decline, neuropathy, and an increased risk of neurodegenerative diseases like Parkinson's or dementia
Discover how Nooms innovative model could redefine the future of weight management #Noom #GLP1 #WeightLoss #HealthInnovation #DigitalHealth #MetabolicHealth #Healthcare #Wellness #ObesityTreatment #MedicalNews #PublicHealth #HealthcareTrends #ClinicalResearch #medtigo #ForYou To view or add a comment, sign in Global Obesity Care, Global Challenges uniting science, education, and physicians to tackle one of the worlds most pressing health burdens